Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol versus valsartan + amlodipine for hypertension in adults
IRCT20240701062299N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Bisoprolol with Valsartan + amlodipine (2 arms). Primary endpoint: Blood pressure control with bisoprolol monotherapy. Started Aug 2022; status: completed.
02
Drugs
bisoprololvalsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20240701062299N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240701062299N2.